Chin Ken Min, Chua Darren W Q, Lee Ser Yee, Chan Chung Yip, Goh Brian K P
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore.
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital; Duke-NUS Medical School, Singapore.
J Minim Access Surg. 2021 Jan-Mar;17(1):69-75. doi: 10.4103/jmas.JMAS_247_19.
Minimally invasive liver resection (MILR) has been increasingly adopted over the past decade, and its application has been expanded to the management of extrapancreatic biliary malignancies (EPBMs). We aimed to evaluate the peri- and post-operative outcome of patients undergoing MILR for suspected EPMB.
Forty-four consecutive patients who underwent MILR with a curative intent for EPBM at Singapore General Hospital between 2011 and 2018 were identified from a prospectively maintained surgical database. Clinical and operative data were analysed and compared to provide information and make comparisons on peri- and post-operative outcomes.
A total of 26, 5 and 13 patients underwent MILR for intrahepatic cholangiocarcinoma (ICC), perihilar cholangiocarcinoma (PHC) and gallbladder carcinoma (GBCA), respectively. Six major hepatectomies were performed, of which one was laparoscopic assisted and another was robot assisted. Ten patients underwent posterosuperior segmentectomies. There was one open conversion. The mean operative time was 266.5 min, and the mean blood loss was 379 ml. The mean length of hospital stay was 4.7 days with no incidences of 30- and 90-day mortality. The rate of recurrence-free survival (RFS) was 75% (at least 12-month follow-up). There was a significantly higher rate of robot-assisted procedures in patients undergoing MILR for GBCA/PHC as compared to ICC (P = 0.034). Patients undergoing posterosuperior segmentectomies required longer operative time (P = 0.018) with an increased need for (P = 0.001) and duration of (P = 0.025) Pringles manoeuvre. There were no differences in operative time, blood loss, morbidity, mortality or RFS between the above groups.
Minimally invasive surgery can be adopted safely with a low open conversion rate for EPBMs.
在过去十年中,微创肝切除术(MILR)的应用越来越广泛,其应用范围已扩展到胰外胆管恶性肿瘤(EPBMs)的治疗。我们旨在评估疑似EPMB患者接受MILR的围手术期和术后结局。
从一个前瞻性维护的手术数据库中识别出2011年至2018年期间在新加坡总医院接受MILR治疗EPBM且具有治愈意图的44例连续患者。分析并比较临床和手术数据,以提供围手术期和术后结局的信息并进行比较。
分别有26例、5例和13例患者接受了MILR治疗肝内胆管癌(ICC)、肝门部胆管癌(PHC)和胆囊癌(GBCA)。进行了6例大肝切除术,其中1例为腹腔镜辅助,另1例为机器人辅助。10例患者接受了后上段切除术。有1例转为开放手术。平均手术时间为266.5分钟,平均失血量为379毫升。平均住院时间为4.7天,无30天和90天死亡率。无复发生存率(RFS)为75%(至少随访12个月)。与ICC患者相比,接受MILR治疗GBCA/PHC的患者机器人辅助手术的比例明显更高(P = 0.034)。接受后上段切除术的患者手术时间更长(P = 0.018),Pringles手法的使用需求增加(P = 0.001)且持续时间延长(P = 0.025)。上述组之间在手术时间、失血量、发病率、死亡率或RFS方面无差异。
对于EPBMs,微创外科手术可以安全采用,开放转换率低。